Cell and Gene Logistics

31. Investors Trust Strong Supply Chains 3/2/2026

    Investors now value operational maturity as much as science. Early, intentional supply‑chain planning shows scalability, lowers risk, and builds confidence in reliable growth.

32. Green Supply Chains Rarely Start With A Pledge; Target Waste Instead 2/27/2026

    Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.

33. Best Practices For Managing The Logistics And Distribution Of CGTs 2/23/2026

    Site infrastructure, formulary timelines, and storage capabilities create barriers between approval and patient access. Planning for these operational realities separates successful launches from stalled ones.

34. U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/18/2026

    Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

35. Active Versus Passive Shipping Solutions For Clinical Shipments 2/13/2026

    Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.

36. Sourcing, Analyzing, And Ensuring Quality In CGT Raw Materials 2/4/2026

    Biopharmaceutical sponsors should utilize phase-appropriate strategies to mitigate risks like material variability and regulatory scrutiny in cell and gene therapy development. These proactive measures ensure quality and supply chain security, stabilizing delivery of these complex treatments despite significant cost and consistency challenges.

37. Evolving Methods Of Bulk Freezing 1/29/2026

    Learn how the transition to plate-based freezing with single-use technologies improves scalability and contamination control while ensuring uniform thermal transfer for high-value bulk drug substances.

38. ProConnex® Single-Use Bags 1/23/2026

    State-of-the-art flexible and rigid single-use bags engineered specifically for bioprocessing applications. Optimize handling and transfer of high-value liquids with our range of bottles, carboys, 2D bags, and 3D bags.

39. Single-Use Solutions: Biological Fluid Management 1/22/2026

    Ensure efficiency in your upstream and downstream biopharma workflows with Charter Medical’s biological fluid management solutions.

40. Single-Use Solutions: Cell Growth 1/21/2026

    From early-stage research to commercial-scale production, Charter Medical delivers integrated solutions that streamline your biopharma workflows.